Newly established immune laboratory, cell laboratory and Q-PCR laboratory.

The biological analysis of more than 10 varieties passed the CFDI on-site inspection.

A bioanalysis platform integrating small molecules and biomacromolecules and a comprehensive research platform for drug metabolism and PK/PD will be built.

Passed ISO17025 laboratory accreditation and obtained certificate.

Accepted the on-site inspection of our laboratory by CFDI for the first time and passed it smoothly.

Successfully passed the verification ability test of the macromolecular drug bevacizumab and obtained the certificate.

Completion of related research work on PK research, excretion and metabolite identification of the first innovative drug.

Successfully organized a nationwide bioanalysis academic conference, reported more than 20 experts, and more than 400 guests, and achieved good social response.

Successfully passed Beijing High-tech Enterprise Certification in November 2018

Laboratory software and hardware are built and put into use

Effectiveness and application of quality management system

Completion of the first biological analysis project and successful submission of application materials

Beijing Scinovo Laboratories Co., Ltd. was incorporated